OKYO Pharma Ltd (NASDAQ:OKYO) announced it will participate in the virtual BTIG Biotechnology Conference 2026, taking place July 28 to 29.
OKYO CEO Robert Dempsey, chief financial officer Keeren Shah and chief medical officer Flavio Mantelli will represent the clinical-stage biopharmaceutical company. Investors interested in one-on-one meetings with management can schedule them through their BTIG representative.